Evidence map›Paper›PMID 39856708›Full record

ArticleRespiratory research2025

Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients.

Julien Guiot, Monique Henket, Fanny Gester, Béatrice André, Benoit Ernst, Anne-Noelle Frix, Dirk Smeets, Simon Van Eyndhoven, Katerina Antoniou, Lennart Conemans and 12 more

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Julien GuiotDepartment of Respiratory Medicine, University Hospital of Liège, Liège, Belgium. J.Guiot@chuliege.be.
Monique HenketDepartment of Respiratory Medicine, University Hospital of Liège, Liège, Belgium.
Fanny GesterDepartment of Respiratory Medicine, University Hospital of Liège, Liège, Belgium.
Béatrice AndréDepartment of Rheumatology, University Hospital of Liège, Liège, Belgium.
Benoit ErnstDepartment of Respiratory Medicine, University Hospital of Liège, Liège, Belgium.
Anne-Noelle FrixDepartment of Respiratory Medicine, University Hospital of Liège, Liège, Belgium.
Dirk Smeetsicometrix, Leuven, Belgium.
Simon Van Eyndhovenicometrix, Leuven, Belgium.
Katerina AntoniouLaboratory of Cellular and Molecular Pneumonology, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Lennart ConemansDepartment of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Janine Gote-SchnieringDepartment of Rheumatology and Immunology, Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Hans SlabbynckDepartment of Pneumology, ZNA Middelheim, Antwerpen, Belgium.
Michael KreuterMainz Center for Pulmonary Medicine, Department of Pneumology, Department of Pulmonary, ZfT, Mainz University Medical Center and Department of Pulmonary, Critical Care and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.
Jacobo SellaresDepartment of Pneumology, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Ioannis TomosDepartment of Pulmonary Medicine, SOTIRIA Chest Diseases Hospital of Athens, Athens, Greece.
Guang YangBioengineering Department and Imperial-X, Imperial College London, London, UK.
Clio RibbensDepartment of Rheumatology, University Hospital of Liège, Liège, Belgium.
Renaud LouisDepartment of Respiratory Medicine, University Hospital of Liège, Liège, Belgium.
Vincent CottinNational Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, member of ERN-LUNG, Hospices Civils de Lyon, UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.
Sara TomassettiUnit of Interventional Pulmonology, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
Vanessa SmithDepartment of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Simon L F WalshNational Heart and Lung Institute, Imperial College London, London, UK.

Funding

European Respiratory Society PROFILE.netFIRS (CHU Liège)
6 · The paper itself

Abstract

backgroundSystemic sclerosis (SSc) is a rare connective tissue disease associated with rapidly evolving interstitial lung disease (ILD), driving its mortality. Specific imaging-based biomarkers associated with the evolution of lung disease are needed to help predict and quantify ILD.

methodsWe evaluated the potential of an automated ILD quantification system (icolung

resultsWe evaluated a group of 75 patients suffering from SSc-ILD, either limited or diffuse, of whom 30 presented progressive pulmonary fibrosis (PPF). The patients presenting PPF exhibited more extensive lesions (in % of total lung volume (TLV)) based on image analysis than those without PPF: 3.93 (0.36-8.12)* vs. 0.59 (0.09-3.53) respectively, whereas pulmonary functional test showed a reduction in Force Vital Capacity (FVC)(pred%) in patients with PPF compared to the others : 77 ± 20% vs. 87 ± 19% (p < 0.05). Modifications of FVC and diffusing capacity of the lungs for carbon monoxide (DLCO) over time were correlated with longitudinal radiological ILD modifications (r=-0.40, p < 0.01; r=-0.40, p < 0.01 respectively).

conclusionAI-based automatic quantification of lesions from chest-CT images in SSc-ILD is correlated with physiological parameters and can help in disease evaluation. Further clinical multicentric validation is necessary in order to confirm its potential in the prediction of patient's outcome and in treatment management.

Indexed as

Artificial IntelligenceLungLung Diseases, InterstitialScleroderma, SystemicTomography, X-Ray ComputedAdultAgedCohort StudiesFemaleHumansMaleMiddle AgedPredictive Value of TestsRespiratory Function TestsRetrospective StudiesArtificial intelligenceComputed tomographyInterstitial lung diseasePulmonary function testsSystemic sclerosis

Identifiers

PMID39856708
PMCPMC11762107

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.